Director's Messages

Joni Rutter highlights crimps in the translational pipeline and approaches for developing new treatments twice as fast over the next decade.

Joni Rutter describes how the center is working toward the goal of increasing inclusivity in research and in the translational science workforce.

Joni Rutter shares three approaches for increasing the number of treatments in the drug development pipeline within the next 10 years.

Joni Rutter promotes Rare Disease Day at NIH and shares two key areas of rare diseases research that need to be addressed.

Joni Rutter reflects on NCATS’ 10th anniversary and her vision for developing more treatments for all people more quickly.

Joni Rutter reflects on NCATS’ mission ahead of the center’s 10-year anniversary and discusses the proposed new medical research agency, the Advanced Research Projects Agency for Health (ARPA-H).

Joni Rutter reflects on the accomplishments of NIH Director Francis Collins, M.D., Ph.D., who announced his plans to step down from his position at the end of the year.

Joni Rutter shares how NCATS will collaborate with federal agencies, academic researchers and the private sector in the Antiviral Program for Pandemics and apply its proficiency in drug discovery and development to accelerate antiviral development.

Joni Rutter reflects on lessons learned from the COVID-19 pandemic and what comes next. She highlights NCATS’ efforts to combat the pandemic and how they can be applied to all diseases.

Christopher P. Austin, M.D., reflects on his 10 years as NCATS director in his last message. He highlights some of NCATS’ accomplishments since the Center was created a decade ago.